Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Fish and Richardson
Merck
Farmers Insurance
Express Scripts
Argus Health
Colorcon
Daiichi Sankyo

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,472,393

« Back to Dashboard

Summary for Patent: 4,472,393
Title: 3,20-Dioxo-1,4-pregnadiene-17.alpha.-ol 17-aromatic heterocycle carboxylates
Abstract:This invention relates to novel 3,20-dioxo-1,4-pregnadiene-17.alpha.-ol 17-aromatic heterocyclic carboxylates, to pharmaceutical formulations thereof, and their use in the treatment and control of inflammatory conditions.
Inventor(s): Shapiro; Elliot L. (Cedar Grove, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:06/403,276
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,472,393
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 4,472,393

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,472,393

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
82100490Jan 25, 1982

International Family Members for US Patent 4,472,393

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland 78111 ➤ Try a Free Trial
European Patent Office 0057401 ➤ Try a Free Trial 94C0002 Belgium ➤ Try a Free Trial
European Patent Office 0057401 ➤ Try a Free Trial 94C0003 Belgium ➤ Try a Free Trial
European Patent Office 0057401 ➤ Try a Free Trial 94C0004 Belgium ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Department of Justice
Medtronic
Argus Health
US Army
Boehringer Ingelheim
Mallinckrodt
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.